References
- Atreya, I., Atreya, R., Neurath, M.F., 2008. NF-kappaB in inflammatory bowel disease. J Intern Med. 263(6):591-6.10.1111/j.1365-2796.2008.01953.x18479258
- Ben-Horin, S., Chowers, Y., 2011. Review article: loss of response to anti-TNF treatments in Crohn’s disease. Aliment Pharmacol Ther., 33(9): 987-95.10.1111/j.1365-2036.2011.04612.x21366636
- Bonavina, L., Arini, A., Ficano, L., Iannuzziello, D., Pasquale, L., Aragona, S.E., Ciprandi, G., 2019. On Digestive Disorders ISG. Abincol® (Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, Lactobacillus delbrueckii LDD01), an oral nutraceutical, pragmatic use in patients with chronic intestinal disorders. Acta Biomed. 90(7-S):8-12. doi: 10.23750/abm.v90i7-S.8649.
- Chapman, T.M., Plosker, G.L., Figgitt, D.P., 2006. VSL#3 probiotic mixture: a review of its use in chronic inflammatory bowel diseases. Drugs, 66(10): 1371-87.10.2165/00003495-200666100-0000616903771
- Cheifetz, A.S., Gianotti, R., Luber, R., Gibson, P.R., 2017. Complementary and alternative medicines used by patients with Inflammatory Bowel Diseases. Gastroenterology, 152(2): 415-429.10.1053/j.gastro.2016.10.00427743873
- Coskun, M., Olsen, J., Seidelin, J.B., Nielsen, O.H., 2011. MAP kinases in inflammatory bowel disease. Clinica chimica acta; international journal of clinical chemistry, 412(7-8): 513-520.10.1016/j.cca.2010.12.02021185271
- Dieleman, L.A., Goerres, M. S., Arends, A., Sprengers, D., Torrice, C., Hoentjen, F., Grenther, W. B., Sartor, R. B., 2003. Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut, 52(3): 370-376.10.1136/gut.52.3.370177355212584218
- Duary RK, Batish VK, Grover S., 2014. Immunomodulatory activity of two potential probiotic strains in LPS-stimulated HT-29 cells. Genes Nutr. 9(3):398. doi:10.1007/s12263-014-0398-210.1007/s12263-014-0398-2402643424682881
- FAO/WHO Organization., 2001. Probiotics in food: health and nutritional properties and guidelines for evaluation: Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria, Cordoba, Argentina, 1-4 October 2001 [and] Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food, London, Ontario, Canada, 30 April -1 May 2002. 2006.
- Friedrich, M., Pohin, M., Powrie, F., 2019. Cytokine Networks in the Pathophysiology of Inflammatory Bowel Disease. Immunity, 50(4): 992-1006.10.1016/j.immuni.2019.03.01730995511
- Haller, D., Bode, C., Hammes, W. P., Pfeifer, A. M. A., Schiffrin, E. J., and Blum, S., 2000. Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures, Gut, 47(1): 79–8710.1136/gut.47.1.79172796210861268
- Hilsden, R.J., Verhoef, M.J., Rasmussen, H., Porcino, A., DeBruyn, J.C., 2011. Use of complementary and alternative medicine by patients with inflammatory bowel disease. Inflamm Bowel Dis, 17(2): 655-62.10.1002/ibd.2136020848543
- Kim, H.G., Lee, S.Y., Kim, N.R., Lee, H.Y., Ko, M.Y., Jung, B.J., Kim, C.M., Lee, J.M., Park, J.H., Han, S.H., 2011. Lactobacillus plantarum lipoteichoic acid down-regulated Shigella flexneri peptidoglycan-induced inflammation Mol. Immunol., 48 (4), 382-39110.1016/j.molimm.2010.07.01121129777
- La Fata, G., Weber, P., Mohajeri, M.H., 2018. Probiotics and the Gut Immune System: Indirect Regulation. Probiotics Antimicrob Proteins, 10(1): 11-21.10.1007/s12602-017-9322-6580139728861741
- Lichtenstein, L., Avni-Biron, I., Ben-Bassat, O., 2016. Probiotics and prebiotics in Crohn’s disease therapies. Best Practice & Research. Clinical Gastroenterology, 30(1): 81–88. doi: 10.1016/j.bpg.2016.02.00210.1016/j.bpg.2016.02.00227048899
- Liu, X.J., Yu, R., Zou, K.F., 2019. Probiotic Mixture VSL#3 Alleviates Dextran Sulfate Sodium-induced Colitis in Mice by Downregulating T Follicular Helper Cells. Curr Med Sci.39(3):371-378. doi: 10.1007/s11596-019-2045-z.10.1007/s11596-019-2045-z31209805
- Livak, K.J., Schmittgen, T.D., 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25(4): 402-8.10.1006/meth.2001.126211846609
- Zaylaa, M., Al Kassaa, I., Alard, J., Peucelle, V., Boutillier, D., Desramaut, J., Dabboussi, F., Pot, B., Grangette, C., 2018. Probiotics in IBD: Combining in vitro and in vivo models for selecting strains with both anti-inflammatory potential as well as a capacity to restore the gut epithelial barrier, Journal of Functional Foods, 47, 304-315, https://doi.org/10.1016/j.jff.2018.05.029.10.1016/j.jff.2018.05.029
- McLean, L.P., Cross, R.K., 2014. Adverse events in IBD: to stop or continue immune suppressant and biologic treatment. Expert Rev Gastroenterol Hepatol. 8(33): 223-40. doi: 10.1586/17474124.2014.881715.10.1586/17474124.2014.881715414008624490595
- Mowat, C., Windsor, A., Ahmad, T., Arnott, I., Driscoll, R., Mitton, S., Orchard, T., Rutter, M., Younge, L., Lees, C., Ho, G.T., Satsangi, J., Bloom, S., 2011. Guidelines for the management of inflammatory bowel disease in adults. Gut, 60(5): 571-607. doi: 10.1136/gut.2010.224154.10.1136/gut.2010.22415421464096
- Owczarek, D., Rodacki, T., Domagała-Rodacka, R., Cibor, D., Mach, T., 2016. Diet and nutritional factors in inflammatory bowel diseases. World Journal of Gastroenterology, 22(3): 895-905. doi: 10.3748/wjg.v22.i3.895.10.3748/wjg.v22.i3.895471604326811635
- Pistol, G.C., Marin, D.E., Dragomir, C., Taranu, I., 2019. Synbiotic combination of prebiotic grape pomace extract and probiotic Lactobacillus sp. reduced important intestinal inflammatory markers and in-depth signalling mediators in lipopolysaccharide-treated Caco-2 cells. British Journal of Nutrition, 2019. 121 (3): 291-305.10.1017/S000711451800341030565527
- Pistol, G.C., Marin, D.E., Taranu, I., 2020. A mixture of Lactobacillus sp. modulates the expression of inflammatory molecules, signalling kinases and nuclear receptors in LPS-treated Caco-2 cell culture model. Archiva Zootechnica, 23(1): 55-72.10.2478/azibna-2020-0006
- Qiao, J., Sun., Z., Liang, D., Li, H., 2020. Lactobacillus salivarius alleviates inflammation via NF-κB signaling in ETEC K88-induced IPEC-J2 cells. J Anim Sci Biotechnol. 11:76. doi: 10.1186/s40104-020-00488-5.10.1186/s40104-020-00488-5739807132774852
- Saez-Lara, M. J., Gomez-Llorente, C., Plaza-Diaz, J., Gil, A., 2015. The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: A systematic review of randomized human clinical trials. BioMed Research International, 2015: 505878. 10.1155/2015/505878.10.1155/2015/505878435248325793197
- Shi, Z., Fultz, R.S., Engevik, M.A., Gao, C., Hall, A., Major, A., Mori-Akiyama, Y., Versalovic, J., 2019. Distinct roles of histamine H1- and H2-receptor signaling pathways in inflammation-associated colonic tumorigenesis. Am J Physiol Gastrointest Liver Physiol. 316(1):G205-G216. doi: 10.1152/ajpgi.00212.2018.10.1152/ajpgi.00212.2018638338530462522
- Taranu, I., Marin, D.E., Braicu, C., Pistol, G.C., Sorescu, I., Pruteanu, L.L., Berindan Neagoe, I., Vodnar, D.C., 2018. In Vitro transcriptome response to a mixture of Lactobacilli strains in intestinal porcine epithelial cell line. International Journal of Molecular Science, 19(7): 1923, doi: 10.3390/ijms1907192310.3390/ijms19071923607384929966337
- Yan, F., Polk, D.B., 2002. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem., 277(52):50959-65. doi: 10.1074/jbc.M207050200.10.1074/jbc.M207050200400699412393915
- Yan, F., Polk, D.B., 2020. Probiotics and probiotic-derived functional factors—mechanistic insights into applications for intestinal homeostasis. Front. Immunol, 11:1428. doi: 10.3389/fimmu.20